Food constituents attenuate monoamine oxidase activity and peroxide levels in C6 astrocyte cells

被引:107
作者
Mazzio, EA [1 ]
Harris, N [1 ]
Soliman, KFA [1 ]
机构
[1] Florida A&M Univ, Coll Pharm & Pharmaceut Sci, Tallahassee, FL 32307 USA
关键词
monoamine oxidase; glial; C6; cells; polyphenolics; hydrogen peroxide;
D O I
10.1055/s-2006-957530
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
Glial cell monoamine oxidase (MAO) activity has been implicated as a contributor to oxidative neuronal damage associated with various neurodegenerative diseases. The attenuation of MAO activity may provide protection against oxidative neurodegeneration. In this investigation, the presence of MAO-B in rat C6 astrocyte cells was substantiated by dose-dependent inhibition of enzyme activity in the presence of chlorgyline-HCl and L-deprenyl. The present study evaluated various dietary-derived food constituents for evidence of inhibition on oxidative deamination of monoamines or peroxide radical trapping capacity. Results of this investigation indicate that compounds which inhibit C6 glial cell MAO enzyme activity or scavenge peroxide product include chlorogenic acid, (+)-catechin, taxifolin, (-)-epigallocatechin gallate (EGCG), fisetin, coenzyme Q(0), curcumin, sesamol, morin, sesame oil, silymarin, green tea, ferulic acid, caffeic acid, and rutin hydrate. The results of this study indicate that dietary compounds can attenuate peroxide production in glial cells by either inhibiting the deamination of monoamines or acting as a free radical scavenger.
引用
收藏
页码:603 / 606
页数:4
相关论文
共 20 条
  • [1] L-DEPRENYL CONFERS SPECIFIC PROTECTION AGAINST MPTP-INDUCED PARKINSONS DISEASE-LIKE MOVEMENT DISORDER IN THE GOLDFISH
    ADEYEMO, OM
    YOUDIM, MBH
    MARKEY, SP
    MARKEY, CJ
    POLLARD, HB
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1993, 240 (2-3) : 185 - 193
  • [2] AMINOFF MJ, 1994, WESTERN J MED, V161, P303
  • [3] CHIUEH CC, 1994, ANN NY ACAD SCI, V738, P25
  • [4] Does monoamine oxidase type B play a role in dopaminergic nerve cell death in Parkinson's disease?
    Damier, P
    Kastner, A
    Agid, Y
    Hirsch, EC
    [J]. NEUROLOGY, 1996, 46 (05) : 1262 - 1269
  • [5] INCREASED LEVELS OF LIPID HYDROPEROXIDES IN THE PARKINSONIAN SUBSTANTIA-NIGRA - AN HPLC AND ESR STUDY
    DEXTER, DT
    HOLLEY, AE
    FLITTER, WD
    SLATER, TF
    WELLS, FR
    DANIEL, SE
    LEES, AJ
    JENNER, P
    MARSDEN, CD
    [J]. MOVEMENT DISORDERS, 1994, 9 (01) : 92 - 97
  • [6] Inhibition of monoamine oxidase B in the brains of smokers
    Fowler, JS
    Volkow, ND
    Wang, GJ
    Pappas, N
    Logan, J
    MacGregor, R
    Alexoff, D
    Shea, C
    Schlyer, D
    Wolf, AP
    Warner, D
    Zezulkova, I
    Cilento, R
    [J]. NATURE, 1996, 379 (6567) : 733 - 736
  • [7] BIOCHEMISTRY OF PARKINSONS-DISEASE WITH SPECIAL REFERENCE TO THE DOPAMINERGIC SYSTEMS
    HIRSCH, EC
    [J]. MOLECULAR NEUROBIOLOGY, 1994, 9 (1-3) : 135 - 142
  • [8] (-)-DEPRENYL INCREASES THE LIFE-SPAN AS WELL AS ACTIVITIES OF SUPEROXIDE-DISMUTASE AND CATALASE BUT NOT OF GLUTATHIONE-PEROXIDASE IN SELECTIVE BRAIN-REGIONS IN FISCHER RATS
    KITANI, K
    KANAI, S
    CARRILLO, MC
    IVY, GO
    [J]. PHARMACOLOGY OF AGING PROCESSES: METHODS OF ASSESSMENT AND POTENTIAL INTERVENTIONS, 1994, 717 : 60 - 71
  • [9] AUTOXIDATION OF DOPAMINE - A COMPARISON OF LUMINESCENT AND SPECTROPHOTOMETRIC DETECTION IN BASIC SOLUTIONS
    KLEGERIS, A
    KORKINA, LG
    GREENFIELD, SA
    [J]. FREE RADICAL BIOLOGY AND MEDICINE, 1995, 18 (02) : 215 - 222
  • [10] KNOLL J, 1993, J NEURAL TRANSM-GEN, P69